News | Mobile C-Arms | November 20, 2020

Ziehm Imaging Showcases its Mobile C-arms and Intraoperative Decision Support Solutions at RSNA20

Ziehm Imaging will showcase its leading portfolio of mobile C-arms and advanced pre- and intraoperative image-based decision support solutions on its virtual RSNA 2020 booth

November 20, 2020 — Ziehm Imaging will showcase its leading portfolio of mobile C-arms and advanced pre- and intraoperative image-based decision support solutions on its virtual RSNA 2020 booth.

Highlights on display include:

  • Powerful combination for advanced 3-D intraoperative navigation: the fully motorized Ziehm Vision RFD Hybrid Edition1 and the patented EndoNaut fusion technology by Therenva provide physicians with optimal guidance during endovascular interventions
  • Ziehm Vision RFD 3D sets standards with an installed base of close to 1,000 systems: the Ziehm flagship model is ideally suited for high-end orthopedic, trauma and spinal interventions as well as for highly specialized maxillofacial and cochlear procedures
  • First mini C-arm family for pediatric imaging: the Orthoscan TAU systems are the first mini C-arms in the market approved for pediatrics

Visit the Ziehm Imaging and Orthoscan booth on the RSNA virtual exhibition floor via ebooth.ziehm.com. The virtual booth offers a guided tour, product videos and much more on the proven Ziehm Imaging C-arm portfolio and the Orthoscan TAU product family.

Related Content

Chest X-ray image of patient with lung injury due to vaping. Image courtesy of UC Regents #COVID19 #pandemic

Chest X-ray image of patient with lung injury due to vaping. Image courtesy of UC Regents

News | Coronavirus (COVID-19) | November 19, 2020
November 19, 2020 — A UC Davis Health ped
1H-MR spectra of 3 consecutive patients with COVID-19. Upper row: Axial FLAIR images at the corona radiata level show representative MRS voxels (black squares) from sampled periventricular regions. Lower row: Corresponding spectrum (black) and LCModel fit (red) from each patient acquired at TE = 30 ms (upper row) and TE = 288 ms (lower row). A, A patient with COVID-19-associated multifocal necrotizing leukoencephalopathy shows diffuse patchy WM lesions with markedly increased Cho and decreased NAA, as well

1H-MR spectra of 3 consecutive patients with COVID-19. Upper row: Axial FLAIR images at the corona radiata level show representative MRS voxels (black squares) from sampled periventricular regions. Lower row: Corresponding spectrum (black) and LCModel fit (red) from each patient acquired at TE = 30 ms (upper row) and TE = 288 ms (lower row). A, A patient with COVID-19-associated multifocal necrotizing leukoencephalopathy shows diffuse patchy WM lesions with markedly increased Cho and decreased NAA, as well as elevated Lac. B, A patient with COVID-19 after recent PEA cardiac arrest with subtle FLAIR hyperintense white matter changes also shows elevated Cho/Cr and decreased NAA/Cr ratios. However, these derangements are less severe than in the patient in A. There is no clear elevation of Lac. C, A patient with COVID-19 without encephalopathy or recent severe hypoxia has normal Cho/Cr, with mildly decreased NAA/Cr and no lactate elevation. Cho, Choline; NAA, N-Acetyl-Aspartate; mI, Myo-Inositol; Lac, Lactate; Glx, Glutamate + Glutamine. Image courtesy of AJNR

News | Coronavirus (COVID-19) | November 19, 2020
November 19, 2020 — One of the first spectroscopic imaging-based studies of neurological injury in...
Reduces the complexity of reporting for screening and diagnostic MRI eams to deliver time-saving and patient safety benefits
News | MRI Breast | November 18, 2020
November 18, 2020 — ...